Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ADMA BIOLOGICS, INC. shareholders approved Election of Bryant E. Fong to serve as a Class I director until the Company’s 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or until his earlier resignation, removal or death at the 2023-06-06 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-06
Exact text from the filing
The vote with respect to the election of the director was as follows: Nominee For Withheld Broker Non-Votes Bryant E. Fong 104,032,764 43,796,163 31,645,337
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ADMA BIOLOGICS, INC. shareholders approved Ratification of the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-06
Exact text from the filing
The vote with respect to the ratification of the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was as follows: For Against Abstain 178,835,482 407,959 230,823
View on SEC.gov